{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:57Z","timestamp":1792782717741,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MRFF KickStarter Scheme- La Trobe University","id":[{"id":"https:\/\/ror.org\/01rxfrp27","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The University of Sydney","id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The use of electronic patient-reported outcome measures (ePROMs) has demonstrated benefits in oncology; however, their use in hematological malignancies remains limited. We aimed to identify bespoke ePROM platforms used in hematology settings and describe their features, acceptability, usability, feasibility, implementation and uptake rates, and outcome data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted following PRISMA 2020 guidelines. Electronic databases (MEDLINE, EMBASE, CINAHL, PsycINFO, Cochrane) and Google Play were searched for studies and mobile applications (apps) reporting on ePROM platforms in hematological cancer populations. Data were extracted about the following: characteristics, features, uses, and patient or clinician-reported data on platform acceptability, usability, feasibility, implementation, and evaluation outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen total platforms were identified from 18 studies (reporting 13 unique ePROM platforms) and one platform known to authors. No additional platforms were identified through Google Play search. The included platforms were used in hematological research, clinical care, and registry settings and captured symptoms and quality of life using validated and customized PROMs. Delivery modes included websites and apps that featured automated prompts, clinician alerts, graphical feedback, and electronic medical record integration. Overall,\u00a0usability was reported to be\u00a0high; most platforms were acceptable to patients and clinicians. Feasibility and uptake varied, but several studies reported high patient engagement (&gt;\u200980% completion rates). Positive outcomes included reduced symptom burden, improved treatment adherence, and enhanced patient-clinician communication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The diversity of identified platforms reflects the wide range of\u00a0hematological\u00a0diseases, treatments, and care settings in which ePROMs may be applied, highlighting their flexibility and adaptability. Existing ePROM platforms used in\u00a0hematological\u00a0cancers vary\u00a0substantially in\u00a0features, purposes, and settings. Future work should focus on tailoring content, supporting implementation, and evaluating the impact of ePROM platforms on patient, clinician, and service outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11264-y","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:01:54Z","timestamp":1790362914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Electronic patient-reported outcome platforms used in hematological cancers: a systematic review"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0912-9087","authenticated-orcid":false,"given":"Jessica","family":"Nikolovski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza A.","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Acret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgu","family":"Serce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe K.","family":"McQuilten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica M.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"1","key":"11264_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N et al (2023) Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J 13(1):82","journal-title":"Blood Cancer J"},{"key":"11264_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2024.102716","volume":"95","author":"R Shah","year":"2025","unstructured":"Shah R et al (2025) Updated cancer burden in oldest old: a population-based study using 2022 Globocan estimates. Cancer Epidemiol 95:102716","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"11264_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40164-025-00684-x","volume":"14","author":"T Pan","year":"2025","unstructured":"Pan T et al (2025) Global burden and trends of hematologic malignancies based on Global Cancer Observatory 2022 and Global Burden of Disease 2021. Exp Hematol Oncol 14(1):98","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"11264_CR4","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1038\/bcj.2015.29","volume":"5","author":"P Allart-Vorelli","year":"2015","unstructured":"Allart-Vorelli P et al (2015) Haematological cancer and quality of life: a systematic literature review. Blood Cancer J 5(4):e305\u2013e305","journal-title":"Blood Cancer J"},{"key":"11264_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/00469580211025211","volume":"58","author":"M Malik","year":"2021","unstructured":"Malik M, Rizwan I, Hussain A (2021) Health related quality of life among blood cancer patients in Pakistan: a cross sectional survey. Inquiry 58:00469580211025211","journal-title":"Inquiry"},{"issue":"6","key":"11264_CR6","doi-asserted-by":"publisher","first-page":"e396","DOI":"10.1200\/JOP.2014.001537","volume":"10","author":"OO Odejide","year":"2014","unstructured":"Odejide OO et al (2014) End-of-life care for blood cancers: a series of focus groups with hematologic oncologists. J Oncol Pract 10(6):e396\u2013e403","journal-title":"J Oncol Pract"},{"issue":"3","key":"11264_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.clml.2024.07.018","volume":"25","author":"A Major","year":"2025","unstructured":"Major A, Dueck AC, Thanarajasingam G (2025) SOHO state of the art updates and next questions| measuring patient-reported outcomes (PROs) and treatment tolerability in patients with hematologic malignancies. Clin Lymphoma Myeloma Leuk 25(3):142\u2013155","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"11264_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1182\/blood-2017-03-737403","volume":"130","author":"F Efficace","year":"2017","unstructured":"Efficace F, Gaidano G, Lo-Coco F (2017) Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice? Blood 130(7):859\u2013866","journal-title":"Blood"},{"key":"11264_CR9","unstructured":"U.S. Food and Drug Safety Administration, Patient-reported outcome measures: use in medical product development to support labeling claims. Guidance for industry. Silver Spring, MD: Office of Communications, Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration, 2009."},{"issue":"6","key":"11264_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557\u2013565","journal-title":"J Clin Oncol"},{"key":"11264_CR11","doi-asserted-by":"publisher","DOI":"10.1056\/CAT.21.0134","author":"EC Makhni","year":"2021","unstructured":"Makhni EC et al (2021) The benefits of capturing PROMs in the EMR. NEJM Catal. https:\/\/doi.org\/10.1056\/CAT.21.0134","journal-title":"NEJM Catal"},{"issue":"8","key":"11264_CR12","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1200\/JCO.2010.29.8315","volume":"29","author":"CS Cleeland","year":"2011","unstructured":"Cleeland CS et al (2011) Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol 29(8):994\u20131000","journal-title":"J Clin Oncol"},{"key":"11264_CR13","unstructured":"Nikolovski, J., Bridging the Gap: Exploring the Use of Patient-Reported Outcome Measures in Clinical Care Settings. 2024, University of Sydney."},{"issue":"2","key":"11264_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/j.ajkd.2019.02.011","volume":"74","author":"OL Aiyegbusi","year":"2019","unstructured":"Aiyegbusi OL et al (2019) Patient and clinician perspectives on electronic patient-reported outcome measures in the management of advanced CKD: a qualitative study. Am J Kidney Dis 74(2):167\u2013178","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"11264_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s41687-023-00554-2","volume":"7","author":"BG Glenwright","year":"2023","unstructured":"Glenwright BG et al (2023) Facilitators and barriers to implementing electronic patient-reported outcome and experience measures in a health care setting: a systematic review. J Patient Report Outcomes 7(1):13","journal-title":"J Patient Report Outcomes"},{"issue":"1","key":"11264_CR16","doi-asserted-by":"publisher","DOI":"10.2196\/15588","volume":"3","author":"J Meirte","year":"2020","unstructured":"Meirte J et al (2020) Benefits and disadvantages of electronic patient-reported outcome measures: systematic review. JMIR Perioper Med 3(1):e15588","journal-title":"JMIR Perioper Med"},{"issue":"1","key":"11264_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41687-023-00544-4","volume":"7","author":"A Payne","year":"2023","unstructured":"Payne A et al (2023) Patient and clinician-reported experiences of using electronic patient reported outcome measures (ePROMs) as part of routine cancer care. J Patient Report Outcomes 7(1):42","journal-title":"J Patient Report Outcomes"},{"issue":"1","key":"11264_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12969-021-00551-z","volume":"19","author":"JY Yu","year":"2021","unstructured":"Yu JY et al (2021) Electronic forms for patient reported outcome measures (PROMs) are an effective, time-efficient, and cost-minimizing alternative to paper forms. Pediatr Rheumatol 19(1):67","journal-title":"Pediatr Rheumatol"},{"issue":"14","key":"11264_CR19","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","volume":"32","author":"G Kotronoulas","year":"2014","unstructured":"Kotronoulas G et al (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32(14):1480\u20131501","journal-title":"J Clin Oncol"},{"key":"11264_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-083346","author":"J Nikolovski","year":"2024","unstructured":"Nikolovski J (2024) Acceptability and timing considerations when administering patient-reported outcome measures (PROMs) among people with chronic health conditions who are culturally and linguistically diverse (CALD): a qualitative study protocol. BMJ Open. https:\/\/doi.org\/10.1136\/bmjopen-2023-083346","journal-title":"BMJ Open"},{"issue":"7","key":"11264_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11136-026-04277-x","volume":"35","author":"J Nikolovski","year":"2026","unstructured":"Nikolovski J et al (2026) Physiotherapist and nurse perspectives on the acceptability and timing of patient-reported outcome measures in clinical practice: balancing standardisation and flexibility. Qual Life Res 35(7):177","journal-title":"Qual Life Res"},{"issue":"7","key":"11264_CR22","doi-asserted-by":"publisher","first-page":"E178","DOI":"10.1002\/ajh.25815","volume":"95","author":"EM Moore","year":"2020","unstructured":"Moore EM et al (2020) Patient-reported outcome measures in multiple myeloma: real-time reporting to improve care (My-PROMPT)\u2014a pilot randomized controlled trial. Am J Hematol 95(7):E178\u2013E181","journal-title":"Am J Hematol"},{"issue":"1","key":"11264_CR23","volume":"1","author":"J Popay","year":"2006","unstructured":"Popay J et al (2006) Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme Version 1(1):b92","journal-title":"A product from the ESRC methods programme Version"},{"issue":"3","key":"11264_CR24","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00520-019-04932-9","volume":"28","author":"AL Bryant","year":"2020","unstructured":"Bryant AL et al (2020) Pilot randomized trial of an electronic symptom monitoring and reporting intervention for hospitalized adults undergoing hematopoietic stem cell transplantation. Support Care Cancer 28(3):1223\u20131231","journal-title":"Support Care Cancer"},{"issue":"4","key":"11264_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s11136-015-1125-1","volume":"25","author":"N Brochmann","year":"2016","unstructured":"Brochmann N et al (2016) A new internet-based tool for reporting and analysing patient-reported outcomes and the feasibility of repeated data collection from patients with myeloproliferative neoplasms. Qual Life Res 25(4):835\u2013846","journal-title":"Qual Life Res"},{"issue":"2","key":"11264_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/cncr.35021","volume":"130","author":"F Efficace","year":"2024","unstructured":"Efficace F et al (2024) Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia. Cancer 130(2):287\u2013299","journal-title":"Cancer"},{"issue":"1","key":"11264_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40814-023-01307-0","volume":"9","author":"P Geerts","year":"2023","unstructured":"Geerts P et al (2023) Rationale and development of an e-health application to deliver patient-centered care during treatment for recently diagnosed multiple myeloma patients: pilot study of the MM E-coach. Pilot Feasibility Stud 9(1):85","journal-title":"Pilot Feasibility Stud"},{"issue":"3","key":"11264_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jpainsymman.2006.08.007","volume":"33","author":"ED Hacker","year":"2007","unstructured":"Hacker ED, Ferrans CE (2007) Ecological momentary assessment of fatigue in patients receiving intensive cancer therapy. J Pain Symptom Manage 33(3):267\u2013275","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"11264_CR29","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00520-012-1618-1","volume":"21","author":"SD King","year":"2013","unstructured":"King SD, Fitchett G, Berry DL (2013) Screening for religious\/spiritual struggle in blood and marrow transplant patients. Support Care Cancer 21(4):993\u20131001","journal-title":"Support Care Cancer"},{"issue":"1","key":"11264_CR30","doi-asserted-by":"publisher","DOI":"10.2196\/44533","volume":"9","author":"MR LeBlanc","year":"2023","unstructured":"LeBlanc MR et al (2023) A mobile app to support self-management in patients with multiple myeloma or chronic lymphocytic leukemia: pilot randomized controlled trial. JMIR Cancer 9(1):e44533","journal-title":"JMIR Cancer"},{"key":"11264_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2023.102455","volume":"68","author":"T Rosenberg","year":"2024","unstructured":"Rosenberg T et al (2024) Making decisions for follow-up chemotherapy based on digital patient reported outcomes data in patients with multiple myeloma and other M protein diseases\u2013a mixed method study. Eur J Oncol Nurs 68:102455","journal-title":"Eur J Oncol Nurs"},{"issue":"4","key":"11264_CR32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s11764-018-0693-9","volume":"12","author":"KL Syrjala","year":"2018","unstructured":"Syrjala KL et al (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv 12(4):560\u2013570","journal-title":"J Cancer Surviv"},{"key":"11264_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2022.100964","volume":"29","author":"R Warsame","year":"2022","unstructured":"Warsame R et al (2022) A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology. Contemp Clin Trials Commun 29:100964","journal-title":"Contemp Clin Trials Commun"},{"issue":"6","key":"11264_CR34","first-page":"312","volume":"39","author":"CE Song","year":"2021","unstructured":"Song CE, An M (2021) The self-management smartphone application for cancer survivors, ReLive: development and usability testing. Comput Inform Nurs CIN 39(6):312\u2013320","journal-title":"Comput Inform Nurs CIN"},{"issue":"12","key":"11264_CR35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s00520-024-08985-3","volume":"32","author":"MN Patel","year":"2024","unstructured":"Patel MN et al (2024) Symptom experience of patients undergoing treatment for multiple myeloma: a longitudinal real-world electronic patient-reported outcomes study. Support Care Cancer 32(12):802","journal-title":"Support Care Cancer"},{"issue":"3","key":"11264_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.18620\/ctt-1866-8836-2024-13-3-62-69","volume":"13","author":"TP Nikitina","year":"2024","unstructured":"Nikitina TP et al (2024) Use of electronic patient-reported outcome system in routine clinical practice in patients with lymphoproliferative neoplasms undergoing autologous hematopoietic stem cell transplantation: a feasibility study. Cell Ther Transplant 13(3):62\u201369","journal-title":"Cell Ther Transplant"},{"key":"11264_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.826040","volume":"12","author":"F Efficace","year":"2022","unstructured":"Efficace F et al (2022) Physicians\u2019 perceptions of clinical utility of a digital health tool for electronic patient-reported outcome monitoring in real-life hematology practice. Evidence from the GIMEMA-ALLIANCE platform. Front Oncol 12:826040","journal-title":"Front Oncol"},{"issue":"11","key":"11264_CR38","doi-asserted-by":"publisher","DOI":"10.2196\/18982","volume":"4","author":"N Biran","year":"2020","unstructured":"Biran N et al (2020) Adaptation and evaluation of a symptom-monitoring digital health intervention for patients with relapsed and refractory multiple myeloma: pilot mixed-methods implementation study. JMIR Form Res 4(11):e18982","journal-title":"JMIR Form Res"},{"issue":"6","key":"11264_CR39","doi-asserted-by":"publisher","DOI":"10.2196\/26022","volume":"23","author":"J Lehmann","year":"2021","unstructured":"Lehmann J et al (2021) Using the computer-based health evaluation system (CHES) to support self-management of symptoms and functional health: evaluation of hematological patient use of a web-based patient portal. J Med Internet Res 23(6):e26022","journal-title":"J Med Internet Res"},{"key":"11264_CR40","doi-asserted-by":"publisher","DOI":"10.2196\/46017","volume":"25","author":"J Lehmann","year":"2023","unstructured":"Lehmann J et al (2023) Adherence to patient-reported symptom monitoring and subsequent clinical interventions for patients with multiple myeloma in outpatient care: longitudinal observational study. J Med Internet Res 25:e46017","journal-title":"J Med Internet Res"},{"issue":"6","key":"11264_CR41","volume":"28","author":"M Sztankay","year":"2019","unstructured":"Sztankay M et al (2019) Complementing clinical cancer registry data with patient reported outcomes: a feasibility study on routine electronic patient-reported outcome assessment for the Austrian Myelome Registry. Eur J Cancer Care 28(6):e13154","journal-title":"Eur J Cancer Care"},{"issue":"3","key":"11264_CR42","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s11764-011-0182-x","volume":"5","author":"KL Syrjala","year":"2011","unstructured":"Syrjala KL et al (2011) Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation. J Cancer Surviv 5(3):292\u2013304","journal-title":"J Cancer Surviv"},{"key":"11264_CR43","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.24.00092","volume":"8","author":"DG Stuijt","year":"2024","unstructured":"Stuijt DG et al (2024) Remote patient monitoring using mobile health technology in cancer care and research: patients\u2019 views and preferences. JCO Clin Cancer Inform 8:e2400092","journal-title":"JCO Clin Cancer Inform"},{"key":"11264_CR44","doi-asserted-by":"publisher","DOI":"10.2147\/oarrr.s296541","author":"S Chahal","year":"2021","unstructured":"Chahal S, Biln N, Clarke B (2021) Patient perspectives on a digital mobile health application for RA. Open Access Rheumatol Res Rev. https:\/\/doi.org\/10.2147\/oarrr.s296541","journal-title":"Open Access Rheumatol Res Rev"},{"key":"11264_CR45","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S220207","author":"M-Y Tang","year":"2019","unstructured":"Tang M-Y et al (2019) What kind of a mobile health app do patients truly want? A pilot study among ambulatory surgery patients. Patient Prefer Adherence. https:\/\/doi.org\/10.2147\/PPA.S220207","journal-title":"Patient Prefer Adherence"},{"issue":"7","key":"11264_CR46","doi-asserted-by":"publisher","DOI":"10.2196\/14187","volume":"7","author":"R Richards","year":"2019","unstructured":"Richards R et al (2019) The preferences of patients with cancer regarding apps to help meet their illness-related information needs: qualitative interview study. JMIR Mhealth Uhealth 7(7):e14187","journal-title":"JMIR Mhealth Uhealth"},{"issue":"1","key":"11264_CR47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12955-020-01438-5","volume":"18","author":"OL Aiyegbusi","year":"2020","unstructured":"Aiyegbusi OL et al (2020) Patient and clinician opinions of patient reported outcome measures (PROMs) in the management of patients with rare diseases: a qualitative study. Health Qual Life Outcomes 18(1):177","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"11264_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1017\/S0266462316000271","volume":"32","author":"A R\u00fcther","year":"2016","unstructured":"R\u00fcther A et al (2016) Aspects of patient reported outcomes in rare diseases: a discussion paper. Int J Technol Assess Health Care 32(3):126\u2013130","journal-title":"Int J Technol Assess Health Care"},{"issue":"1","key":"11264_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13023-018-0810-x","volume":"13","author":"A Slade","year":"2018","unstructured":"Slade A et al (2018) Patient reported outcome measures in rare diseases: a narrative review. Orphanet J Rare Dis 13(1):61","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"11264_CR50","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s11136-025-03913-2","volume":"34","author":"J Nikolovski","year":"2025","unstructured":"Nikolovski J et al (2025) Strategies to promote the completion of patient-reported outcome measures by culturally and linguistically diverse and Indigenous Peoples in clinical care settings: a systematic review. Qual Life Res 34(6):1541\u20131551","journal-title":"Qual Life Res"},{"issue":"3","key":"11264_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/jorc.70069","volume":"52","author":"J Nikolovski","year":"2026","unstructured":"Nikolovski J et al (2026) Developing a set of core patient-reported outcomes for kidney replacement therapy: a modified Delphi study. J Ren Care 52(3):e70069","journal-title":"J Ren Care"},{"key":"11264_CR52","unstructured":"Nikolovski J, Potts H, Papamichos E, Nikolovski T, Jang K, White L, Morton RL, Foster M, Dadich A (2026) How we ask matters: a scoping review of innovative technologies for patient-reported measure completion. Under review"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11264-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:48:44Z","timestamp":1792086524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11264-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11264"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11264-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1018"}}